Operating Grant: Innovative Biomedical and Clinical HIV Vaccine Research | Canadian Institutes of Health Research (CIHR)

Value: Maximum $250,000


The CIHR HIV/AIDS Research Initiative is responsible for the research components of the Federal Initiative to Address HIV/AIDS in Canada. The 2015-2020 HIV/AIDS Research Initiative Strategic Plan highlights “Enable discovery research” as one of three strategic directions. In support of this strategic direction, the goal of this funding opportunity is to foster a culture of innovation in Canada by supporting innovative or high-risk biomedical and clinical projects related to preventive and therapeutic vaccines with potential for transformative advances in the area of HIV/AIDS. It will also support the next generation of researchers by funding grant proposals from promising new investigators.

The Operating Grant: Innovative Biomedical and Clinical HIV Vaccine Research will support innovative or high-risk biomedical and clinical research directly relevant to the priority objectives of the CIHR HIV/AIDS Research Initiative.

The specific objectives of this funding opportunity are:

  • Enable new and established investigators to undertake innovative biomedical and clinical HIV vaccine research projects in new areas of investigation or take previous discoveries in new directions
  • Promote the development and testing of novel HIV vaccine research tools and methodologies
  • Support high-risk HIV vaccine research projects with the potential for high impact, breakthrough and/or transformative advances


  • The Nominated Principal Applicant (NPA) must be an independent researcher at an eligible institution (See Institutional Eligibility Requirements for eligibility process and associated timelines)
  • To be eligible for funds under the New Investigator funding pool, the Nominated Principal Applicant must be within 5 years of their first independent academic appointment (in which they were actively engaged in research)

Eligible Expenses:

Grant funds must contribute towards the direct costs of the research for which the funds were awarded, and the benefits should be directly attributable to the grant.

Deadline: Currently closed. Future deadline to be determined.

Contact: CIHR Contact Centre | 1-888-603-4178 | support@cihr-irsc.gc.ca

Website: https://www.researchnet-recherchenet.ca/rnr16/vwOpprtntyDtls.do?prog=2576&view=currentOpps&org=CIHR&type=EXACT&resultCount=25&sort=program&next=1&all=1&masterList=true

By | 2018-08-07T02:29:31+00:00 July 27th, 2018|Categories: Grants|0 Comments

Leave A Comment